Distinct molecular features of FLNC mutations, associated with different clinical phenotypes
Cytoskeleton · 2025
DOI: 10.1002/cm.21922 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytoskeleton, 2025. Verfasst von E S Klimenko und 13 weiteren Autor:innen. Beteiligte Einrichtung: Almazov National Medical Research Centre, Institute of Molecular Biology and Genetics, Saint-Petersburg, Russia. Hauptthemen laut MEDLINE: Mutation, Filamins, Cardiomyopathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The present work was supported by Russian Science Foundation grant number 20-15-00271П.
Abstract (Originalsprache)
Filamin С is a key an actin‐binding protein of muscle cells playing a critical role in maintaining structural integrity and sarcomere organization. FLNC mutations contribute to various types of cardiomyopathies and myopathies through potentially different molecular mechanisms. Here, we described the impact of two clinically distinct FLNC variants (R1267Q associated with arrhythmogenic cardiomyopathy and V2264M associated with restrictive cardiomyopathy) on calcium homeostasis, electrophysiology, and gene expression profile of iPSC‐derived patient‐specific cardiomyocytes. We demonstrated that R1267Q FLNC variant leads to greater disturbances in calcium dynamics, Nav1.5 kinetics and action potentials compared to V2264M variant. These functional characteristics were accompanied by transcriptome changes in genes linked to action potential and sodium transport as well as structural cardiomyocyte genes. We suggest distinct molecular effects of two FLNC variants linked to different types of cardiomyopathies in terms of myofilament structure, electrophysiology, ion channel function and intracellular calcium homeostasis providing the molecular the bases for their different clinical phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Almazov National Medical Research Centre, Institute of Molecular Biology and Genetics, Saint-Petersburg, Russia.
- Karolinska Institutet, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.
Förderung
- The present work was supported by Russian Science Foundation grant number 20-15-00271П
Zitieren
APA
Klimenko, E. S., Zaytseva, A. K., Sorokina, M. Y., Perepelina, K. I., Rodina, N. L., Nikitina, E. G., Sukhareva, K. S., Khudiakov, A. A., Vershinina, T. L., Muravyev, A. S., Mikhaylov, E. N., Pervunina, T. M., Vasichkina, E. S., & Kostareva, A. A. (2025). Distinct molecular features of FLNC mutations, associated with different clinical phenotypes. Cytoskeleton. https://doi.org/10.1002/cm.21922
Vancouver
Klimenko ES, Zaytseva AK, Sorokina MY, Perepelina KI, Rodina NL, Nikitina EG, et al. Distinct molecular features of FLNC mutations, associated with different clinical phenotypes. Cytoskeleton. 2025. doi:10.1002/cm.21922
BibTeX
@article{Klimenko2025,
author = {Klimenko, E S and Zaytseva, A K and Sorokina, M Yu and Perepelina, K I and Rodina, N L and Nikitina, E G and Sukhareva, K S and Khudiakov, A A and Vershinina, T L and Muravyev, A S and Mikhaylov, E N and Pervunina, T M and Vasichkina, E S and Kostareva, A A},
title = {Distinct molecular features of FLNC mutations, associated with different clinical phenotypes},
journal = {Cytoskeleton},
year = {2025},
doi = {10.1002/cm.21922}
}
EUVIMED